AZTR Azitra
- 0.203
- +0.008+3.95%
Azitra News
Azitra Presents Preclinical Data From ATR-04 At Society Of Investigative Dermatology Annual Meeting
ATR-04 is in development for epidermal growth factor receptor inhibitor (EGFRi)-induced dermal toxicity, which affects approximately 150,000 patients in the USReduces methicillin-resistant S. aureus b
Optimistic Outlook Justifies Buy Rating for Azitra Inc Amidst Promising Product Development and Strategic Partnerships
Express News | Azitra Inc - Atr-12 Safe and Well Tolerated in Minipigs
Azitra, Inc. Announces Positive Preclinical Data of ATR-12 and Clinical Design in Netherton Syndrome Presented at the ASGCT Annual Meeting
Azitra, Inc. (NYSE American: AZTR), a clinical-stage biopharmaceutical company focused on developing innovative therapies for precision dermatology, today announced preclinical data from the Company's platform and pipeline.
Express News | Azitra Q1 2024 EPS $(0.15) Up From $(3.00) YoY; Service Revenue $0 Down From $113,300 YoY
Express News | Azitra Inc - Qtrly Shr Loss $0.15
Azitra | 10-Q: Quarterly report
Azitra 1Q Loss/Shr 15c >AZTR
Azitra 1Q Loss/Shr 15c >AZTR
Azitra, Inc. Announces Q1 2024 Financial Results and Provides Business Updates
Azitra, Inc. (NYSE American: AZTR), a clinical-stage biopharmaceutical company focused on developing innovative therapies for precision dermatology, today reported financial results for the three months ended March 31, 2024, and provided a business update.
12 Health Care Stocks Moving In Monday's After-Market Session
GainersAgape ATP (NASDAQ:ATPC) shares rose 23.0% to $0.32 during Monday's after-market session. The market value of their outstanding shares is at $24.9 million. FibroGen (NASDAQ:FGEN) shares increase
Catalyst Watch: Disney Earnings, Apple iPad Event and Fed Speakers Back on the Circuit
Why Nucor Shares Are Trading Lower? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Shares of Nucor Corporation (NYSE:NUE) fell sharply during Tuesday's session after the company reported worse-than-expected quarterly financial results.Nucor reported quarterly earnings of $3.46 per s
Why Hibbett Shares Are Trading Higher By 18%; Here Are 20 Stocks Moving Premarket
Shares of Hibbett, Inc. (NASDAQ:HIBB) rose sharply in today's pre-market trading after the company agreed to be acquired by JD Sports Fashion for $87.50 per share in cash, in a $1.1 billion transactio
Express News | Azitra Shares Are Trading Higher After the Company Announced New Preclinical Data Will Be Presented at the American Society of Gene and Cell Therapy Meeting
Express News | Azitra, Inc. Announces New Preclinical Data to Be Presented at the American Society of Gene and Cell Therapy Meeting
Azitra, Inc. to Present New Data at Three Upcoming Scientific Conferences in May 2024
Azitra, Inc. (NYSE American: AZTR), a clinical-stage biopharmaceutical company focused on developing innovative therapies for precision dermatology, today announced it will be presenting promising new preclinical data from its platform built (or optimized) to discover treatments for serious skin diseases at three upcoming scientific and medical conferences
Silo Pharma And 3 Other Stocks Under $5 Insiders Are Buying
The Dow Jones index closed lower by over 200 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders int
Azitra(AZTR.US) Officer Buys US$10,034.08 in Common Stock
$Azitra(AZTR.US)$ Officer Staskey Norm purchased 47,600 shares of Common Stock on Mar 29, 2024 at an average price of $0.2108 for a total value of $10,034.08.Source: Announcement What is statement of
Buy Rating Endorsed for Azitra Inc. on Strong Pipeline and Financial Stability
Azitra GAAP EPS of -$1.83, Revenue of $0.69M
Analysis
Price Target
No Data
